Aug 24, 2023

Genotyping of HIV-1 to Detect Drug Resistance

Posted by in category: biotech/medical

To address the HIV surveillance needs of the global community, the Applied Biosystems HIV-1 Genotyping Kit with Integrase offers broad genotyping coverage of HIV-1 Group M subtypes from extracted viral RNA from plasma and dried blood spot (DBS) samples to detect resistance to protease inhibitors, nucleoside reverse-transcriptase inhibitors, non-nucleoside reverse-transcriptase inhibitors, and integrase inhibitors.

This HIV-1 resistance kit harnesses gold-standard Sanger sequencing technology to amplify and reliably sequence the diverse and rapidly evolving HIV-1 virus.

This product employs assays for HIV-1 genotyping licensed from the U.S. Centers for Disease Control and Prevention.

Leave a reply